STOCK TITAN

British American Tobacco buys back 122K shares

A repurchase agreement runs from October 13 through December 23; Bruce Sewell joins the board January 1, with committee changes beginning November 30.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

British American Tobacco p.l.c. reported share purchases under its buyback programme, including 122,343 ordinary shares purchased on October 23 at a volume weighted average price of 4,438.15p per share. Under a separate agreement with Merrill Lynch International, purchases are scheduled from October 13 through the close of business on December 23, 2026. Shareholder authority permits the company to purchase a maximum of 217,492,219 shares, which are to be cancelled.

After the purchases and cancellations reported through October 23, the company says it will have 2,155,557,220 ordinary shares in issue excluding treasury shares and 132,648,864 shares in treasury. It issued 9,636 shares under its Sharesave Scheme between September 1 and September 30; 1,417,845 shares not yet in issue remained subject to the Block Admission. The Capital Group Companies, Inc. reported 18.023677% of voting rights, representing 388,574,533 voting rights, after the threshold was crossed on October 21.

Bruce Sewell will join the Board as an independent Non-Executive Director on January 1, 2027, and join the Audit and Nominations Committees. From November 30, Véronique Laury will leave the Audit Committee and join the Remuneration Committee, while Serpil Timuray will move from the Remuneration Committee to the Audit Committee.

Ordinary shares purchased 122,343 shares October 23, 2026 buyback
Volume weighted average purchase price 4,438.15p per share October 23, 2026 buyback
Maximum share-purchase authority 217,492,219 shares Authority granted at the 2026 AGM
Ordinary shares in issue excluding treasury shares 2,155,557,220 shares Following purchases and cancellations reported through October 23, 2026
Shares in treasury 132,648,864 shares Following purchases and cancellations reported through October 23, 2026
Shares issued under Sharesave Scheme 9,636 shares September 1–30, 2026
Shares subject to the Block Admission 1,417,845 shares Not yet in issue
Capital Group voting rights 18.023677% (388,574,533 voting rights) Position reported after the threshold was crossed on October 21, 2026
Voting Rights Figure regulatory
"the “Voting Rights Figure”"
Block Admission technical
"the Company’s existing block admission of shares"
Partnership Share Scheme financial
"under the Partnership Share Scheme"
volume weighted average price financial
"Volume weighted average price paid per share"
The volume weighted average price (VWAP) is a way to measure the average price of a security, such as a stock, over a specific period, taking into account how many units were traded at each price. It’s similar to calculating the average cost of items bought when some are more frequently purchased than others. Investors use VWAP to assess whether a security is being bought or sold at a fair price during trading.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were BTI's latest reported buyback purchases?

British American Tobacco purchased 122,343 ordinary shares on October 23, at a volume weighted average price of 4,438.15p per share. The company said the purchased shares are to be cancelled.

When will BTI's new share-purchase arrangement run?

The agreement with Merrill Lynch International provides for purchases from October 13 through the close of business on December 23, 2026. Merrill Lynch will make its trading decisions independently of, and uninfluenced by, the company, within pre-set parameters and shareholder authority.

How many shares did BTI issue under its Sharesave Scheme in September?

The company issued 9,636 ordinary shares under the Sharesave Scheme between September 1 and September 30, 2026. A further 1,417,845 ordinary shares not yet in issue remained subject to the Block Admission.

What voting-rights position did The Capital Group Companies report for BTI?

The Capital Group Companies, Inc. reported 18.023677% of voting rights, or 388,574,533 voting rights, after the threshold was crossed on October 21, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

  

 

 

FORM 6-K 

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

November 2, 2026

 

Commission File Number: 001-38159 

 

 

 

BRITISH AMERICAN TOBACCO P.L.C.

(Translation of registrant’s name into English)

  

 

 

Globe House

4 Temple Place

London WC2R 2PG

United Kingdom

(Address of principal executive office)

  

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

 

 

 
 

 

This report includes materials as exhibits that have been published and made available by British American Tobacco p.l.c. as of November 2, 2026.

 

 

EXHIBIT INDEX

 

Exhibit   Description  
     
Exhibit 1   Press Release entitled “British American Tobacco p.l.c. (the “Company”) - Voting Rights and Capital” dated October 1, 2026.
     
Exhibit 2   Press Release entitled “British American Tobacco p.l.c. (the “Company”) - Issue of Shares” dated October 1, 2026.
     
Exhibit 3   Press Release entitled “British American Tobacco p.l.c. (the “Company”) - Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated October 2, 2026.
     
Exhibit 4   Press Release entitled “Transaction in own shares” dated October 5, 2026.
     
Exhibit 5   Press Release entitled “British American Tobacco p.l.c. (“the Company”) - Share Buyback Programme” dated October 7, 2026.
     
Exhibit 6   Press Release entitled “British American Tobacco p.l.c. (“the Company”) - Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated October 9, 2026.
     
Exhibit 7   Press Release entitled “Transaction in own shares” dated October 12, 2026.
     
Exhibit 8   Press Release entitled “British American Tobacco p.l.c. (“the Company”) - Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated October 15, 2026.
     
Exhibit 9   Press Release entitled “Transaction in own shares” dated October 19, 2026.
     
Exhibit 10   Press Release entitled “British American Tobacco p.l.c. (“the Company”) - Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated October 20, 2026.
     
Exhibit 11   Press Release entitled “British American Tobacco p.l.c. - TR-1: Notification of major holdings” dated October 23, 2026.
     
Exhibit 12   Press Release entitled “Transaction in own shares” dated October 26, 2026.
     
Exhibit 13   Press Release entitled “British American Tobacco p.l.c. (the “Company” or “BAT”) - Board and Committee Changes” dated October 28, 2026.
     
     
     
     
     
     

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

  British American Tobacco p.l.c.  
       
       
  By: /s/ Christopher Worlock
    Name: Christopher Worlock  
    Title:  Assistant Secretary  
       

 

Date: November 2, 2026

 

 

 

Exhibit 1

 

British American Tobacco p.l.c. (the “Company”) – Voting Rights and Capital

 

In conformity with the Disclosure Guidance and Transparency Rules provision 5.6.1, we notify the market of the following:

 

That, as at 30 September 2026, being the last day of trading for that month, the Company’s issued share capital consisted of 2,157,761,532 ordinary shares of 25p each (“Shares”) with voting rights (the “Voting Rights Figure”).

 

As at 30 September 2026, the Company held 132,648,864 Shares in Treasury.

 

The Voting Rights Figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their voting rights interest, or a change to that interest, in the Company under the FCA’s Disclosure Guidance and Transparency Rules.

 

Nancy Jiang

Senior Assistant Company Secretary

British American Tobacco p.l.c.

 

01 October 2026

 

 

Exhibit 2

 

British American Tobacco p.l.c. (“the Company”)

 

01 October 2026

 

Issue of Shares

 

In accordance with PRM 1.6.4R, the Company (LEI: 213800FKA5MF17RJKT63) confirms that between 1 September 2026 and 30 September 2026 it has issued and allotted 9,636 ordinary shares of 25 pence each (ISIN GB0002875804) “Shares” in connection with the British American Tobacco p.l.c. Sharesave Scheme.

 

The Shares were admitted to trading on the London Stock Exchange Main Market under the Company’s existing block admission of shares for this purpose dated 3 March 2025 (the “Block Admission”). 1,417,845 ordinary shares (not yet in issue) remain subject to the Block Admission.

 

The Shares rank equally and are fully fungible with the existing issued ordinary shares of the Company.

 

Following this issuance of Shares, the Company confirms that as at 30 September 2026, the Company’s issued share capital consisted of 2,157,761,532 Shares with voting rights and 132,648,864 Shares held in Treasury.

 

Nancy Jiang
Senior Assistant Company Secretary

 

 

Enquiries:

 

Media Centre

press_office@bat.com | @BATplc

 

Investor Relations

Victoria Buxton | IR_team@bat.com

 

 

Exhibit 3

 

British American Tobacco p.l.c.

(“the Company”)

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

On 30 September 2026 the independent Trustee of the British American Tobacco Group Employee Trust released the following number of British American Tobacco p.l.c. ordinary shares of 25p each (the “Shares”) granted to the following person discharging managerial responsibilities under the Restricted Share Plan. Subsequent sales of shares are also set out below.

 

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Pascale Meulemeester
2 Reason for the notification
a) Position/status Regional Director, Asia-Pacific, Middle East and Africa
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name British American Tobacco p.l.c.
b) LEI 213800FKA5MF17RJKT63
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Transaction 1
a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 25p each

 

GB0002875804

b) Nature of the transaction Shares released under the Restricted Share Plan
c) Price(s) and volume(s)        
  Price(s) Volume(s)  
  £nil 770  
       
d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

770

 

£nil

e) Date of the transaction 2026-09-30
f) Place of the transaction Outside a trading venue
Transaction 2
a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 25p each

 

GB0002875804

b) Nature of the transaction Sale of shares to meet tax liability arising on vesting of Restricted Share Plan awards
c) Price(s) and volume(s)        
  Price(s) Volume(s)  
  £41.803879 364  
       
d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

364

 

£15,216.61

e) Date of the transaction 2026-09-30
f) Place of the transaction Outside a trading venue

 

Name of officer of issuer responsible for making notification: Nancy Jiang
Date of notification: 2 October 2026

 

 

Exhibit 4

 

 

British American Tobacco p.l.c. 

 

5 October 2026

 

TRANSACTION IN OWN SHARES  

 

British American Tobacco p.l.c. (the “Company”) announces that in accordance with the authority granted by shareholders at the Company’s Annual General Meeting on 15 April 2026 it purchased the following number of its ordinary shares of 25 pence each (“Shares”) from Goldman Sachs International during the period from 28 September 2026 to 2 October 2026 as part of its buyback programme announced on 18 March 2024:  

 

Date of purchase:  28 September 2026 29 September 2026 30 September 2026 1 October 2026 2 October 2026
Number of ordinary shares of 25 pence each purchased:  125,000 100,000 120,000 165,000 167,870
Highest price paid per share (pence):  4,241.00p 4,198.00p 4,181.00p 4,043.00p 3,997.00p
Lowest price paid per share (pence):  4,199.00p 4,090.00p 4,106.00p 3,988.00p 3,979.00p
Volume weighted average price paid per share (pence): 4,224.29p 4,143.70p 4,135.91p 4,018.15p 3,991.09p

 

The Company intends to cancel the purchased Shares.  

 

Following the purchase and cancellation of these Shares, the Company will have 2,157,210,108 ordinary shares in issue (excluding treasury shares) which carry voting rights and will hold 132,648,864 ordinary shares in treasury. This information may be used by shareholders to determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA’s Disclosure Guidance and Transparency Rules. 

 

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it applies in the UK, a schedule of individual trades carried out by Goldman Sachs International during the period set out above is detailed in the attached:

 

http://www.rns-pdf.londonstockexchange.com/rns/6605X_1-2026-10-5.pdf

http://www.rns-pdf.londonstockexchange.com/rns/6605X_2-2026-10-5.pdf

http://www.rns-pdf.londonstockexchange.com/rns/6605X_3-2026-10-5.pdf

http://www.rns-pdf.londonstockexchange.com/rns/6605X_4-2026-10-5.pdf

http://www.rns-pdf.londonstockexchange.com/rns/6605X_5-2026-10-5.pdf

  

Enquiries: 

 

Investor Relations  

Victoria Buxton | IR_team@bat.com

 

 
 

 

Schedule of purchases - aggregate information 

 

Issuer name  ISIN Code  Transaction date 

Daily total volume

(in number of shares) 

Daily weighted average price

of shares acquired 

Platform 
British American Tobacco p.l.c. GB0002875804 28/09/2026 125,000 4,224.29p LSE
British American Tobacco p.l.c. GB0002875804 28/09/2026 0 0.00p CHIX
British American Tobacco p.l.c. GB0002875804 28/09/2026 0 0.00p BATE
British American Tobacco p.l.c. GB0002875804 29/09/2026 100,000 4,143.70p LSE
British American Tobacco p.l.c. GB0002875804 29/09/2026 0 0.00p CHIX
British American Tobacco p.l.c. GB0002875804 29/09/2026 0 0.00p BATE
British American Tobacco p.l.c. GB0002875804 30/09/2026 120,000 4,135.91p LSE
British American Tobacco p.l.c. GB0002875804 30/09/2026 0 0.00p CHIX
British American Tobacco p.l.c. GB0002875804 30/09/2026 0 0.00p BATE
British American Tobacco p.l.c. GB0002875804 01/10/2026 165,000 4,018.15p LSE
British American Tobacco p.l.c. GB0002875804 01/10/2026 0 0.00p CHIX
British American Tobacco p.l.c. GB0002875804 01/10/2026 0 0.00p BATE
British American Tobacco p.l.c. GB0002875804 02/10/2026 137,870 3,990.99p LSE
British American Tobacco p.l.c. GB0002875804 02/10/2026 30,000 3,991.54p CHIX
British American Tobacco p.l.c. GB0002875804 02/10/2026 0 0.00p BATE

 

 

 

Exhibit 5

 

British American Tobacco p.l.c. (the “Company”)

 

7 October 2026

 

Share Buyback Programme

 

Further to the share buyback programme announcement on 18 March 2024 (“the Programme”), and the subsequent extension of the Programme announced on 10 December 2025, the Company announces that it has entered into an agreement with Merrill Lynch International (“Merrill Lynch”) to purchase ordinary shares of the Company (“Shares”) during the period commencing on 13 October 2026 and ending at the close of business on 23 December 2026.

 

Merrill Lynch will make its trading decisions in relation to the Company’s Shares independently of, and uninfluenced by, the Company.

 

The purpose of the Programme is to reduce the share capital of the Company. The Shares repurchased will be cancelled.

 

Any purchases of Shares by the Company in relation to this announcement will be undertaken within certain pre-set parameters, and in accordance with the Company’s general authority to repurchase shares granted by its shareholders from time to time (at the Company’s 2026 AGM, shareholders granted the Company authority to purchase a maximum of 217,492,219 Shares (the “Authority”)), the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (2016/1052), in each case as such legislation forms part of domestic law by virtue of section 3 of the European Union (Withdrawal) Act 2018 (as amended), and Chapter 9.6 of the Financial Conduct Authority's UK Listing Rules.

 

Pursuant to the Authority, the maximum price which may be paid for a Share is an amount (exclusive of taxes and expenses) equal to the higher of:

 

-     105 per cent of the average market value of a Share as derived from the LSE’s Daily Official List for the five business days immediately preceding the day on which the Share is purchased, in accordance with Listing Rule 9.6.1 of the Listing Rules published pursuant to Part 6 of the Financial Services and Markets Act 2000 (“FSMA”) (the “Listing Rules”); and

 

-    the higher of (i) the price of the last independent trade and (ii) the highest current independent purchase bid on the trading venue where the purchase is carried out, including when the shares are traded on different trading venues, in accordance with Article 3(2) of the UK Safe Harbour Regulation.

 

Enquiries:

 

Investor Relations 

Victoria Buxton: | IR_team@bat.com

 

 

 

Exhibit 6

 

British American Tobacco p.l.c.

(“the Company”)

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

The Company has been notified by the trustee of the British American Tobacco Share Incentive Plan that on 7 October 2026 the following Executive Director and other persons discharging managerial responsibilities purchased British American Tobacco p.l.c. ordinary shares of 25p each (the “Shares”) by way of the Partnership Share Scheme. 

 

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Tadeu Marroco
2 Reason for the notification
a) Position/status Chief Executive
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name British American Tobacco p.l.c.
b) LEI 213800FKA5MF17RJKT63
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 25p each

 

GB0002875804

b) Nature of the transaction Purchase of Shares under the Partnership Share Scheme – a HMRC approved Share Incentive Plan
c) Price(s) and volume(s)        
  Price(s) Volume(s)  
  £40.20 4  
       
d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

4

 

£160.80

e) Date of the transaction 2026-10-07
f) Place of the transaction London Stock Exchange (XLON)

 

 
 

 

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Luciano Comin
2 Reason for the notification
a) Position/status Chief Marketing Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name British American Tobacco p.l.c.
b) LEI 213800FKA5MF17RJKT63
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 25p each

 

GB0002875804

b) Nature of the transaction Purchase of Shares under the Partnership Share Scheme – a HMRC approved Share Incentive Plan
c) Price(s) and volume(s)        
  Price(s) Volume(s)  
  £40.20 4  
       
d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

4

 

£160.80

e) Date of the transaction 2026-10-07
f) Place of the transaction London Stock Exchange (XLON)

 

 
 

 

 

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name James Murphy
2 Reason for the notification
a) Position/status Director, Research and Science
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name British American Tobacco p.l.c.
b) LEI 213800FKA5MF17RJKT63
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 25p each

 

GB0002875804

b) Nature of the transaction Purchase of Shares under the Partnership Share Scheme – a HMRC approved Share Incentive Plan
c) Price(s) and volume(s)        
  Price(s) Volume(s)  
  £40.20 4  
       
d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

4

 

£160.80

e) Date of the transaction 2026-10-07
f) Place of the transaction London Stock Exchange (XLON)

 

 
 

 

 

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name James Barrett
2 Reason for the notification
a) Position/status Director, Business Development
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name British American Tobacco p.l.c.
b) LEI 213800FKA5MF17RJKT63
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 25p each

 

GB0002875804

b) Nature of the transaction Purchase of Shares under the Partnership Share Scheme – a HMRC approved Share Incentive Plan
c) Price(s) and volume(s)        
  Price(s) Volume(s)  
  £40.20 4  
       
d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

4

 

£160.80

e) Date of the transaction 2026-10-07
f) Place of the transaction London Stock Exchange (XLON)

 

 
 

 

 

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Paul McCrory
2 Reason for the notification
a) Position/status Director, Legal and General Counsel
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name British American Tobacco p.l.c.
b) LEI 213800FKA5MF17RJKT63
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 25p each

 

GB0002875804

b) Nature of the transaction Purchase of Shares under the Partnership Share Scheme – a HMRC approved Share Incentive Plan
c) Price(s) and volume(s)        
  Price(s) Volume(s)  
  £40.20 4  
       
d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

4

 

£160.80

e) Date of the transaction 2026-10-07
f) Place of the transaction London Stock Exchange (XLON)

 

 
 

 

 

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Javed Iqbal
2 Reason for the notification
a) Position/status Director, Digital and Information
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name British American Tobacco p.l.c.
b) LEI 213800FKA5MF17RJKT63
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 25p each

 

GB0002875804

b) Nature of the transaction Purchase of Shares under the Partnership Share Scheme – a HMRC approved Share Incentive Plan
c) Price(s) and volume(s)        
  Price(s) Volume(s)  
  £40.20 4  
       
d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

4

 

£160.80

e) Date of the transaction 2026-10-07
f) Place of the transaction London Stock Exchange (XLON)

 

 
 

 

 

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Johan Vandermeulen
2 Reason for the notification
a) Position/status Chief Operating Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name British American Tobacco p.l.c.
b) LEI 213800FKA5MF17RJKT63
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 25p each

 

GB0002875804

b) Nature of the transaction Purchase of Shares under the Partnership Share Scheme – a HMRC approved Share Incentive Plan
c) Price(s) and volume(s)        
  Price(s) Volume(s)  
  £40.20 4  
       
d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

4

 

£160.80

e) Date of the transaction 2026-10-07
f) Place of the transaction London Stock Exchange (XLON)

 

Name of officer of issuer responsible for making notification: Nancy Jiang

Date of notification: 9 October 2026

 

Exhibit 7

 

 

British American Tobacco p.l.c. 

 

12 October 2026

 

TRANSACTION IN OWN SHARES  

 

British American Tobacco p.l.c. (the “Company”) announces that in accordance with the authority granted by shareholders at the Company’s Annual General Meeting on 15 April 2026 it purchased the following number of its ordinary shares of 25 pence each (“Shares”) from Goldman Sachs International during the period from 5 October 2026 to 9 October 2026 as part of its buyback programme announced on 18 March 2024:  

 

Date of purchase:  5 October 2026 6 October 2026 7 October 2026 8 October 2026 9 October 2026
Number of ordinary shares of 25 pence each purchased:  168,340 167,400 165,559 161,542 0
Highest price paid per share (pence):  4,009.00p 4,050.00p 4,079.00p 4,179.00p 0.00p
Lowest price paid per share (pence): 3,948.00p 3,972.00p 4,000.00p 4,091.00p 0.00p
Volume weighted average price paid per share (pence): 3,979.94p 4,002.32p 4,046.89p 4,147.08p 0.00p

 

The Company intends to cancel the purchased Shares.  

 

Following the purchase and cancellation of these Shares, the Company will have 2,156,557,507 ordinary shares in issue (excluding treasury shares) which carry voting rights and will hold 132,648,864 ordinary shares in treasury. This information may be used by shareholders to determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA’s Disclosure Guidance and Transparency Rules. 

 

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it applies in the UK, a schedule of individual trades carried out by Goldman Sachs International during the period set out above is detailed in the attached:

 

http://www.rns-pdf.londonstockexchange.com/rns/6037Y_1-2026-10-12.pdf

http://www.rns-pdf.londonstockexchange.com/rns/6037Y_2-2026-10-12.pdf

http://www.rns-pdf.londonstockexchange.com/rns/6037Y_3-2026-10-12.pdf

http://www.rns-pdf.londonstockexchange.com/rns/6037Y_4-2026-10-12.pdf

 

Enquiries: 

 

Investor Relations 

Victoria Buxton | IR_team@bat.com

 

 
 

 

Schedule of purchases – aggregate information 

 

Issuer name  ISIN Code  Transaction date 

Daily total volume

(in number of shares) 

Daily weighted average price

of shares acquired 

Platform 
British American Tobacco p.l.c. GB0002875804 05/10/2026 168,340 3,979.94p LSE
British American Tobacco p.l.c. GB0002875804 05/10/2026 0 0.00p CHIX
British American Tobacco p.l.c. GB0002875804 05/10/2026 0 0.00p BATE
British American Tobacco p.l.c. GB0002875804 06/10/2026 167,400 4,002.32p LSE
British American Tobacco p.l.c. GB0002875804 06/10/2026 0 0.00p CHIX
British American Tobacco p.l.c. GB0002875804 06/10/2026 0 0.00p BATE
British American Tobacco p.l.c. GB0002875804 07/10/2026 165,559 4,046.89p LSE
British American Tobacco p.l.c. GB0002875804 07/10/2026 0 0.00p CHIX
British American Tobacco p.l.c. GB0002875804 07/10/2026 0 0.00p BATE
British American Tobacco p.l.c. GB0002875804 08/10/2026 161,542 4,147.08p LSE
British American Tobacco p.l.c. GB0002875804 08/10/2026 0 0.00p CHIX
British American Tobacco p.l.c. GB0002875804 08/10/2026 0 0.00p BATE
British American Tobacco p.l.c. GB0002875804 09/10/2026 0 0.00p LSE
British American Tobacco p.l.c. GB0002875804 09/10/2026 0 0.00p CHIX
British American Tobacco p.l.c. GB0002875804 09/10/2026 0 0.00p BATE

 

 

 

Exhibit 8

 

British American Tobacco p.l.c.

(“the Company”)

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Karen Guerra
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name British American Tobacco p.l.c.
b) LEI 213800FKA5MF17RJKT63
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 25p each

 

GB0002875804

b) Nature of the transaction Purchase of ordinary shares
c) Price(s) and volume(s)        
  Price(s) Volume(s)  
  £42.544825 6,000  
       
d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

6,000

 

£255,268.95

e) Date of the transaction 2026-10-14
f) Place of the transaction London Stock Exchange (XLON)

 

Name of officer of issuer responsible for making notification: Nancy Jiang

Date of notification: 15 October 2026

 

Exhibit 9

 

British American Tobacco p.l.c. 

 

19 October 2026

 

TRANSACTION IN OWN SHARES  

 

British American Tobacco p.l.c. (the "Company") announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 15 April 2026 it purchased the following number of its ordinary shares of 25 pence each ("Shares") from Goldman Sachs International and Merrill Lynch International during the period from 12 October 2026 to 16 October 2026 as part of its buyback programme announced on 18 March 2024:  

 

Date of purchase:  12 October 2026 13 October 2026 14 October 2026 15 October 2026 16 October 2026
Number of ordinary shares of 25 pence each purchased:  158,660 128,287  126,358 121,625 123,485
Highest price paid per share (pence):  4,218.00p  4,255.00p  4,277.00p  4,432.00p  4,472.00p
Lowest price paid per share (pence):   4,187.00p  4,195.00p  4,226.00p  4,354.00p  4,311.00p
Volume weighted average price paid per share (pence): 4,206.27p  4,219.93p  4,255.73p  4,388.96p  4,436.97p

 

 

The Company intends to cancel the purchased Shares.  

 

Following the purchase and cancellation of these Shares, the Company will have 2,155,911,533 ordinary shares in issue (excluding treasury shares) which carry voting rights and will hold 132,648,864 ordinary shares in treasury. This information may be used by shareholders to determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules. 

 

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it applies in the UK, a schedule of individual trades carried out by Goldman Sachs International and Merrill Lynch International during the period set out above is detailed in the attached:

 

http://www.rns-pdf.londonstockexchange.com/rns/5192Z_1-2026-10-19.pdf

http://www.rns-pdf.londonstockexchange.com/rns/5192Z_2-2026-10-19.pdf

http://www.rns-pdf.londonstockexchange.com/rns/5192Z_3-2026-10-19.pdf

http://www.rns-pdf.londonstockexchange.com/rns/5192Z_4-2026-10-19.pdf

http://www.rns-pdf.londonstockexchange.com/rns/5192Z_5-2026-10-19.pdf

 

Enquiries: 

 

Investor Relations 

 

Victoria Buxton | IR_team@bat.com

 

 
 

  

Schedule of purchases - aggregate information 

 

Issuer name  ISIN Code  Transaction date 

Daily total volume

(in number of shares) 

Daily weighted

average price of

shares acquired 

Platform 
British American Tobacco p.l.c. GB0002875804 12/10/2026 158,660 4,206.27p LSE
British American Tobacco p.l.c. GB0002875804 12/10/2026 0 0p CHIX
British American Tobacco p.l.c. GB0002875804 12/10/2026 0 0p BATE
British American Tobacco p.l.c. GB0002875804  13/10/2026 128,287 4,219.93p LSE
British American Tobacco p.l.c. GB0002875804 13/10/2026 0 0p CHIX
British American Tobacco p.l.c. GB0002875804 13/10/2026 0 0p BATE
British American Tobacco p.l.c. GB0002875804  14/10/2026 126,358 4,255.73p LSE
British American Tobacco p.l.c. GB0002875804  14/10/2026 0 0p CHIX
British American Tobacco p.l.c. GB0002875804  14/10/2026 0 0p BATE
British American Tobacco p.l.c. GB0002875804  15/10/2026 121,625 4,388.96p LSE
British American Tobacco p.l.c. GB0002875804 15/10/2026 0 0p CHIX
British American Tobacco p.l.c. GB0002875804 15/10/2026 0 0p BATE
British American Tobacco p.l.c. GB0002875804  16/10/2026 123,485 4,436.97p LSE
British American Tobacco p.l.c. GB0002875804 16/10/2026 0 0p CHIX
British American Tobacco p.l.c. GB0002875804 16/10/2026 0 0p BATE

 

 

 

 

Exhibit 10

 

British American Tobacco p.l.c.

(“the Company”)

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Zafar Khan
2 Reason for the notification
a) Position/status Director, Operations
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name British American Tobacco p.l.c.
b) LEI 213800FKA5MF17RJKT63
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 25p each

 

GB0002875804

b) Nature of the transaction Acquisition of shares following the exercise of options held under the 2021 British American Tobacco 3 Year Sharesave Scheme.
c) Price(s) and volume(s)        
  Price(s) Volume(s)  
  £20.76 1445  
       
d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

1,445

 

£29,998.20

e) Date of the transaction 2026-10-19
f) Place of the transaction Outside a trading venue

 

Name of officer of issuer responsible for making notification: Nancy Jiang

Date of notification: 20 October 2026

 

Exhibit 11

 

 

British American Tobacco p.l.c.

TR-1: Notification of major holdings

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: British American Tobacco p.l.c.
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer  
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments  
An event changing the breakdown of voting rights  
Other (please specify)iii:  
3. Details of person subject to the notification obligationiv
Name The Capital Group Companies, Inc.
City and country of registered office (if applicable) Los Angeles, USA
4. Full name of shareholder(s) (if different from 3)v
Name  
City and country of registered office (if applicable)  
Name  
City and country of registered office (if applicable)  
Name  
City and country of registered office (if applicable)  
Name  
City and country of registered office (if applicable)  
Name  
City and country of registered office (if applicable)  
5. Date on which the threshold was crossed or reachedvi: 21/10/2026
6. Date on which issuer notified (DD/MM/YYYY): 22/10/2026

 

 
 

 

7. Total positions of person(s) subject to the notification obligation
 

% of voting rights

attached to shares

(total of 8. A)

% of voting rights through

financial instruments

(total of 8.B 1 + 8.B 2)

Total of both in %

(8.A + 8.B)

Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached 18.023677 0.000000 18.023677 388,574,533
Position of previous notification (if applicable) 17.934796   0.000000 17.934796  

 

 


8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares

Class/type of shares

ISIN code (if possible)

Number of voting rightsix % of voting rights

Direct

(Art 9 of Directive 2004/109/EC)

(DTR5.1)

Indirect

(Art 10 of Directive

2004/109/EC)

(DTR5.2.1)

Direct

(Art 9 of Directive

2004/109/EC)

(DTR5.1)

Indirect

(Art 10 of Directive

2004/109/EC)

(DTR5.2.1)

GB0002875804 Common Stock   291,270,072   13.510298%
US1104481072 Depository Receipt 97,304,461

4.513379%

SUBTOTAL 8. A 388,574,533 18.023677%

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial

instrument

Expiration
date
x
Exercise/
Conversion Period
xi

Number of voting rights that may be acquired

if the instrument is exercised/converted.

% of voting rights
N/A        
    SUBTOTAL 8. B 1    

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument Expiration
date
x
Exercise/
Conversion Period
xi

Physical or cash

settlementxii

Number of voting rights % of voting rights
           
      SUBTOTAL 8.B.2    
 

 

 
 

 

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii  

Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv

(please add additional rows as necessary)

X
Namexv Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold
The Capital Group Companies, Inc. Capital Research and Management Company 17.903643   17.903643%  
The Capital Group Companies, Inc. Capital International, Inc.      
The Capital Group Companies, Inc. Capital Group Private Client Services, Inc.      
The Capital Group Companies, Inc. Capital International Sarl      
The Capital Group Companies, Inc. Capital International Limited      

 

10. In case of proxy voting, please identify:
Name of the proxy holder  
The number and % of voting rights held  
The date until which the voting rights will be held  

 

11. Additional informationxvi

The Capital Group Companies, Inc. (”CGC”) is the parent company of Capital Research and Management Company (”CRMC”) and Capital Bank & Trust Company (”CB&T”). CRMC is a U.S.-based investment management company that serves as investment manager to the American Funds family of mutual funds, other pooled investment vehicles, as well as individual and institutional clients. CRMC and its investment manager affiliates manage equity assets for various investment companies through three divisions, Capital Research Global Investors, Capital International Investors and Capital World Investors. CRMC is the parent company of Capital Group International, Inc. (”CGII”), which in turn is the parent company of six investment management companies (”CGII management companies”): Capital International, Inc., Capital International Limited, Capital International Sàrl, Capital International K.K., Capital Group Private Client Services Inc, and Capital Group Investment Management Private Limited. CGII management companies primarily serve as investment managers to institutional and high net worth clients. CB&T is a U.S.-based registered investment adviser and an affiliated federally chartered bank.

Neither CGC nor any of its affiliates own shares of the Issuer for its own account. Rather, the shares reported on this Notification are owned by accounts under the discretionary investment management of one or more of the investment management companies described above

 

 
 

 

 

Place of completion Los Angeles
Date of completion 22/10/2026

 

 

Name of duly authorised officer of issuer responsible for making notification:

 

Christopher Worlock

Assistant Secretary

British American Tobacco p.l.c.

 

23 October 2026

 

Enquiries:

British American Tobacco Media Centre
+44 (0) 20 7845 2888 (24 hours) | @BATplc

 

Investor Relations

Victoria Buxton | IR_team@bat.com

 

Exhibit 12

 

British American Tobacco p.l.c. 

 

26 October 2026

 

TRANSACTION IN OWN SHARES  

 

British American Tobacco p.l.c. (the "Company") announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 15 April 2026 it purchased the following number of its ordinary shares of 25 pence each ("Shares") from Merrill Lynch International during the period from 19 October 2026 to 23 October 2026 as part of its buyback programme announced on 18 March 2024:  

 

Date of purchase:  19 October 2026 20 October 2026 21 October 2026 22 October 2026 23 October 2026
Number of ordinary shares of 25 pence each purchased:  121,153 122,933 121,340 122,445 122,343
Highest price paid per share (pence):  4,467.00p 4,443.00p  4,426.00p 4,483.00p 4,489.00p
Lowest price paid per share (pence): 4,414.00p  4,388.00p 4,358.00p  4,409.00p  4,406.00p
Volume weighted average price paid per share (pence): 4,437.57p 4,418.79p 4,389.04p 4,456.90p 4,438.15p

 

 

The Company intends to cancel the purchased Shares.  

 

Following the purchase and cancellation of these Shares, the Company will have 2,155,557,220 ordinary shares in issue (excluding treasury shares) which carry voting rights and will hold 132,648,864 ordinary shares in treasury. This information may be used by shareholders to determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules. 

 

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it applies in the UK, a schedule of individual trades carried out by Merrill Lynch International during the period set out above is detailed in the attached:

 

http://www.rns-pdf.londonstockexchange.com/rns/4801A_1-2026-10-26.pdf

http://www.rns-pdf.londonstockexchange.com/rns/4801A_2-2026-10-26.pdf

http://www.rns-pdf.londonstockexchange.com/rns/4801A_3-2026-10-26.pdf

http://www.rns-pdf.londonstockexchange.com/rns/4801A_4-2026-10-26.pdf

http://www.rns-pdf.londonstockexchange.com/rns/4801A_5-2026-10-26.pdf

 

Enquiries: 

 

Investor Relations 

 

Victoria Buxton | IR_team@bat.com

 

 

 

 
 

 

Schedule of purchases - aggregate information 

 

Issuer name  ISIN Code  Transaction date 

Daily total volume

(in number of shares) 

Daily weighted

average price of

shares acquired 

Platform 
British American Tobacco p.l.c. GB0002875804 19/10/2026 121,153 4,437.57p LSE
British American Tobacco p.l.c. GB0002875804 19/10/2026 0 0p CHIX
British American Tobacco p.l.c. GB0002875804 19/10/2026 0 0p BATE
British American Tobacco p.l.c. GB0002875804  20/10/2026 122,933 4,418.79p LSE
British American Tobacco p.l.c. GB0002875804 20/10/2026 0 0p CHIX
British American Tobacco p.l.c. GB0002875804 20/10/2026 0 0p BATE
British American Tobacco p.l.c. GB0002875804  21/10/2026 121,340 4,389.04p LSE
British American Tobacco p.l.c. GB0002875804  21/10/2026 0 0p CHIX
British American Tobacco p.l.c. GB0002875804  21/10/2026 0 0p BATE
British American Tobacco p.l.c. GB0002875804  22/10/2026 122,445 4,456.90p LSE
British American Tobacco p.l.c. GB0002875804 22/10/2026 0 0p CHIX
British American Tobacco p.l.c. GB0002875804 22/10/2026 0 0p BATE
British American Tobacco p.l.c. GB0002875804  23/10/2026 122,343 4,438.15p LSE
British American Tobacco p.l.c. GB0002875804 23/10/2026 0 0p CHIX
British American Tobacco p.l.c. GB0002875804 23/10/2026 0 0p BATE

 

 

 

Exhibit 13

 

British American Tobacco p.l.c. (the “Company” or “BAT”)

 

28 October 2026 

Board and Committee Changes

 

Bruce Sewell will join the Board of British American Tobacco p.l.c. as an independent Non-Executive Director with effect from 1 January 2027 and will be appointed as a member of the Audit and Nominations Committees.

 

Bruce served as Senior Vice President, General Counsel and Secretary of Apple Inc. from 2009 to 2018. As a member of Apple's executive team, his remit covered legal, compliance and ethics, and government relations. Prior to Apple, Bruce spent 14 years at Intel Corporation, latterly as Senior Vice President and General Counsel. Earlier in his career, he was a Partner at Brown & Bain PC.

 

Bruce is currently Lead Independent Director of Vail Resorts, Inc., where he previously chaired the Audit and the Nominating and Governance Committees, and a Director and Chair of the Nominating and Governance Committee of C3.ai, Inc.

 

Commenting on the appointment, Luc Jobin, Chair of the Board, said: "I am pleased to welcome Bruce Sewell to our Board. Bruce brings significant experience in the global technology sector, together with a strong background in engaging with governments and regulators across the U.S., Europe and Asia, and listed-company board experience, including in AI. As we deliver our Horizon 2030 ambitions, his insight will be valuable in navigating a complex regulatory landscape as BAT continues on its ambition to build a Smokeless World."

 

BAT also announces changes to the membership of the Audit and Remuneration Committees, following a review of their composition. With effect from 30 November 2026, Véronique Laury, Non-Executive Director, will step down from the Audit Committee and join the Remuneration Committee, and Serpil Timuray, Non-Executive Director, will step down from the Remuneration Committee and join the Audit Committee.

 

The membership of the Audit and Remuneration Committees as at 1 January 2027 will be:

 

 

Audit Committee Remuneration Committee
Darrell Thomas (Committee Chair) Kandy Anand (Committee Chair)
Uta Kemmerich-Keil Karen Guerra
Bruce Sewell Véronique Laury
Serpil Timuray Matthew Wright

 

 

Enquiries:

 

Media Centre

 

press_office@bat.com | @BATplc

 

Investor Relations

 

Victoria Buxton | IR_team@bat.com

 

 

 

Additional information

 

1.This announcement is made in compliance with the Company's obligations under UKLR 6.4.6.

 

2.There are no additional matters that would require disclosure under UKLR 6.4.8 in respect of this appointment.

Filing Exhibits & Attachments

13 documents

Keep reading